Tag: EMA
BMJ: cerebral venous thrombosis about 20 times more common after AstraZeneca vaccine
The risk of thrombosis at 11 excess events per 100 000 vaccinations are higher than estimated by the European Medicines Agency. More...
EMA: NEW investigation into capillary leak syndrome with AstraZeneca’s COVID-19 coronavirus vaccine Vaxzevria
PRAC has started a review of a safety signal to assess reports of capillary leak syndrome in people who were vaccinated with Vaxzevria (previously COVID-19 Vaccine AstraZeneca). More...
EMA Vaccine Strategy Chief Marco Cavaleri: “increasingly difficult to say that there is no cause and effect relationship between vaccination with AstraZeneca and very rare cases of unusual blood clots”
Marco Cavaleri is responsible for the vaccine strategy of EMA, the European drug agency. More...
EMA: If you have these symptoms after vaccination with AstraZeneca coronavirus serum seek medical help immediately
“Wheezing, chest or stomach pain, swelling or coldness in an arm or leg, severe headache or worsening or blurred vision after vaccination, persistent bleeding, small multiple bruises, reddish or purplish spots or blisters of blood under the skin” – if you have these symptoms after vaccination against Covid with AstraZeneca serum seek medical help immediately and report that you have recently been vaccinated. More...
European Medicines Agency on AstraZeneca coronavirus vaccine: “benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets”
EMA Statement: “the vaccine may be associated with very rare cases of blood clots associated with thrombocytopenia, i.e. More...
EMA: The report from the research group at Rikshospitalet on the connection between AstraZeneca coronavirus vaccine and blood clots has not been assessed by them
The European Medicines Agency (EMA) says that the report from the research group at Oslo Rikshospitalet on the connection between AstraZeneca vaccine and blood clots has not been assessed by them. More...
European Medicines Agency: Carry On Poisoning
EMA: “the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.” More...